Call to watch for rare secondary blood cancer after CAR T-cell therapy
New research led by Peter Mac clinicians will potentially change the way cancer patients are monitored after receiving breakthrough CAR T-cell therapy.
A new paper, published in the New England Journal of Medicine, describes two... Read more